TNBC is considered more aggressive due to its higher likelihood of metastasis, especially to the brain, liver, and lungs, and its tendency to recur within the first three years after treatment. This aggressiveness is partly due to the lack of targeted therapies and the tumor's rapid growth and higher grade.
